Antithrombin III in mesangial IgA nephritis.

Area of Science:

• Nephrology
• Immunology
• Hematology

Background:

• IgA nephritis is a common cause of glomerulonephritis.
• Antithrombin III (A T III) plays a crucial role in anticoagulation.
• The role of A T III in IgA nephritis pathogenesis is not fully understood.

Purpose of the Study:

• To investigate plasma Antithrombin III (A T III) levels in patients with IgA nephritis.
• To explore the correlation between A T III levels and clinical/histological parameters in IgA nephritis.
• To determine if A T III can serve as a prognostic marker in IgA nephritis.

Main Methods:

• Plasma A T III levels were measured in 97 IgA nephritis patients, 30 non-IgA glomerulonephritis patients, and 40 healthy controls.
• Statistical analysis was used to compare A T III levels between groups and correlate them with disease markers.
• Clinical and histological data including proteinuria, segmental sclerosis, crescents, medial hypertrophy, and IgA staining intensity were assessed.

Main Results:

• Mean plasma A T III levels were significantly higher in IgA nephritis patients compared to healthy controls (p < 0.0005).
• A T III levels showed significant correlations with proteinuria, segmental sclerosis, crescents, medial hypertrophy, and IgA staining intensity (p < 0.0001 to p < 0.02).
• Patients with IgA nephritis and elevated A T III levels exhibited more severe proteinuria, segmental sclerosis, and IgA staining.

Conclusions:

• Elevated plasma Antithrombin III (A T III) levels are observed in IgA nephritis.
• Raised A T III levels are associated with increased disease severity in IgA nephritis.
• Plasma A T III may function as a prognostic biomarker for IgA nephritis.